Cannabinoids for chronic pain

Editorial

Steven P Cohen. BMJ. 2008.

. 2008 Jan 26;336(7637):167-8.

doi: 10.1136/bmj.39434.444583.80. Epub 2008 Jan 8.

Abstract

Is effective but research is needed to decide which subgroups of people benefit most

Competing interests: None declared.

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D. Frank B, et al. BMJ. 2008 Jan 26;336(7637):199-201. doi: 10.1136/bmj.39429.619653.80. Epub 2008 Jan 8. BMJ. 2008. PMID: 18182416 Free PMC article. Clinical Trial.

1. Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 200810.1136/bmj.39429.619653.80 - DOI - PMC - PubMed
1. Benedetti F, Vighetti S, Amanzio M, Casadio C, Oliaro A, Bergamasco B, et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998;74:205-11. - PubMed
1. Campbell FA, Tramer MR, Carroll D, Reynolds JM, Moore A, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001;323:13-6. - PMC - PubMed
1. Rice AS, Lever I, Zarnegar R. Cannabinoids and analgesia, with special reference to neuropathic pain. In: McQuay HJ, Kalso E, Moore RA, eds. Systematic reviews in pain research: methodology refined. Seattle: IASP Press, 2007:233-46.
1. Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy. A randomized placebo-controlled trial. Neurology 2007;68:515-21. - PubMed